The U.S. independent diagnostic testing facility market was valued at USD 3.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.52% from 2023 to 2030. The growing demand for diagnostic tests, the rising geriatric population, and the increasing burden of chronic diseases are expected to be major drivers for market growth. According to the U.S. Census Bureau, in mid-2019, there were around 54 million Americans in the age group of 65 years and above. This population is expected to reach more than 83 million by 2040.
Noninvasive diagnostic testing, such as voluntary full-body scans, is gradually being used as a screening tool for precautionary care procedures. Awareness of noninvasive diagnostic testing (X-ray, CT Scan, etc.) among patients as a preventive and less invasive screening method has added to the growth in diagnostic imaging practices. Technological advancements for the early diagnosis of disorders and diseases using less invasive techniques will increase the demand for diagnostic imaging.
Furthermore, growing awareness among people concerning disease management as well as early diagnosis is expected to aid the market growth. The availability of possible cures required for disease conditions coupled with developments in diagnostic tests will boost the demand for radiology tests. Moreover, the rising prevalence of infectious diseases has the potential to impose significant morbidity, death, and financial loss. Over the forecast period, efforts to avoid new infectious diseases will drive market growth.
The market is highly regulated and is subject to various state and federal laws, approvals, and regulations concerning the accreditation and licensing of facilities. All providers offering the technical component of diagnostic MRI, PET/CT, CT, and nuclear medicine must be accredited by 26 CMS authorities (currently the American College of Radiology (ACR), the Intersocietal Accreditation Commission (IAC), and the Joint Commission). The American College of Radiology accredits MRI, CT, nuclear medicine, ultrasound, and mammography institutions.
The initial months of the COVID-19 pandemic caused a significant drop in the non-COVID-19 business of market players as patients avoided routine medical care and most elective and non-emergency procedures were postponed. Industry players were engaged in increasing testing capacity and developing more coronavirus tests. For instance, LabCorp partnered with the CDC to sequence SARS-CoV-2 and better understand how the coronavirus mutates over time.
Moreover, rapid technological advancements to reduce costs and enhance productivity are expected to enhance the market for independent diagnostic testing facilities (IDTFs) during the forecast period. For instance, in August 2019, the Palmetto Imaging subsidiary of MedQuest Associates announced the acquisition of a controlling interest in ImageCare. The acquisition will increase access for patients to affordable imaging and women’s imaging services in South Carolina.
Based on service, the U.S. IDTF market is categorized into radiological/imaging services, cardiac monitoring services, and sleep studies. The radiology/imaging services segment accounted for the largest revenue share of 57.5% in 2022, due to the availability of services available to reduced cost compared to hospitals. The rising awareness regarding the use of technologically advanced systems has created a demand for these services at IDTFs.
The sleep studies segment is expected to witness lower-digit growth during the forecast period. This can be attributed to the less stringent regulations of hospital-based sleep centers and physician-run sleep centers. These services are not limited by stringent regulations and accreditation guidelines such as the Association of Sleep Disorders Centers, the American Academy of Sleep Medicine (AASM), The Joint Commission, and IDTFs.
Moreover, with the growing sleep issues among the population, the demand for sleep studies is rising. According to the CDC statistics, around 32.8% of adults reported short sleep in 2020. Men were the most prevalent population with short sleep duration accounting for around 33.4% of the total men. Lack of sleep leads to various acute health issues which could lead to higher costs of treatments. As per the analysis of Rand Quarterly estimates, in 2020, the projected cost of treating sleep issues in the U.S. was around USD 299 billion to USD 433 billion.
The U.S. IDTF market is highly fragmented, and many players are entering the market. Market players are undertaking strategic initiatives to address the increasing demand for imaging services. Key players are acquiring small-sized players to diversify their service offerings and expand their regional footprint. Thus, there is significant competition among market players. For instance, in April 2021, Somology, Inc. launched an independent diagnostic testing facility to cater to the growing demand for sleep studies. Some prominent players in the U.S. independent diagnostic testing facility market include:
RadNet, Inc.
Vitalistics
Breathe
Texas MRI
The Brookwood Diagnostic Center
ACS Diagnostics, Inc.
Houston MRI & Diagnostic Imaging
TestSmarter Inc.
Duke University and Duke University Health System
Covenant Health Diagnostics
AliveCor, Inc.
Advanced Cardio Services
Diagnostic Medical Testing Inc.
K & T Diagnostic, Inc.
Vestavia Diagnostic Center (VDC)
Advanced Imaging Center
Report Attribute |
Details |
Market size value in 2023 |
USD 3.5 billion |
Revenue forecast in 2030 |
USD 4.8 billion |
Growth rate |
CAGR of 4.52% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Service |
Country scope |
U.S. |
Key companies profiled |
RadNet, Inc.; Equimed Corporation; Vitalistics; Breathe; Texas MRI; The Brookwood Diagnostic Center; ACS Diagnostics, Inc.; Houston MRI & Diagnostic Imaging; TestSmarter Inc.; Duke University and Duke University Health System; Covenant Health Diagnostics; AliveCor, Inc.; Advanced Cardio Services; Diagnostic Medical Testing Inc.; K & T Diagnostic, Inc.; Vestavia Diagnostic Center (VDC); Advanced Imaging Center |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. independent diagnostic testing facility market report based on services:
Service Outlook (Revenue, USD Million, 2018 - 2030)
Radiology/Imaging Services
X-Ray
Computed Tomography (CT)
Magnetic Resonance Angiography (MRA)
Magnetic Resonance Imaging (MRI)
Mammography
Ultrasound
Positron Emission Tomography (PET) Scan
Sleep Studies
Cardiac Monitoring Services
b. The U.S. independent diagnostic testing facility market size was estimated at USD 3.4 billion in 2022 and is expected to reach USD 3.5 billion in 2023.
b. The U.S. independent diagnostic testing facility market is expected to grow at a compound annual growth rate of 4.52% from 2023 to 2030 to reach USD 4.8 billion by 2030.
b. The radiology/imaging service segment dominated the U.S. independent diagnostic testing facility market with a share of 57.52% in 2022. This is attributable to the availability of services available to reduced cost compared to hospitals.
b. Some key players operating in the U.S. independent diagnostic testing facility market include RadNet, Inc.; Equimed Corporation; Vitalistics; Breathe; Texas MRI; The Brookwood Diagnostic Center; ACS Diagnostics, Inc.; Houston MRI & Diagnostic Imaging; TestSmarter Inc.; Duke University and Duke University Health System; Covenant Health Diagnostics; AliveCor, Inc.; Advanced Cardio Services; Diagnostic Medical Testing Inc.; K & T Diagnostic, Inc.; Vestavia Diagnostic Center (VDC); Advanced Imaging Center
b. Key factors that are driving the market growth include the growing demand for diagnostic tests, the rising geriatric population, and the increasing burden of chronic diseases.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."